One of the major obstacles that limits the use of magnetic nanoparticles in biomedical applications is their potential toxicity. In the present study, we evaluated the cytotoxic effects of thiol-functionalized silica-coated iron oxide (Fe3O4@SiO2-SH) nanoparticles using human lung epithelial cells A549. We investigated the effect of Fe3O4@SiO2-SH nanoparticles on the cell viability, proliferation, cell cycle distribution, adhesion, apoptosis, and the orientation of the cytoskeletal networks, as well as on expression of proteins involved in cell death, cell survival, and cell adhesion. We demonstrated that exposure of A549 cells to Fe3O4@SiO2-SH nanoparticles resulted in severe disruption of the actin microfilaments and microtubule cytoskeleton and reduced the size of focal adhesions. Furthermore, cell adhesion was significantly affected as well as the phosphorylation of focal adhesion kinase (FAK), extracellular-signal-regulated kinase (ERK), and p38. Our findings highlight the need for in-depth cytotoxic evaluation of nanoparticles supporting their safer use, especially in biomedical applications.

Department of Biological and Biochemical Sciences Faculty of Chemical Technology University of Pardubice Studentská 573 532 10 Pardubice Czech Republic

Department of Medical Biochemistry Faculty of Medicine in Hradec Králové Charles University Šimkova 870 500 03 Hradec Králové Czech Republic

Institute of Organic Chemistry and Technology Faculty of Chemical Technology University of Pardubice Studentská 573 532 10 Pardubice Czech Republic

Zobrazit více v PubMed

Wang Y., Xu C., Ow H. Commercial Nanoparticles for Stem cell labeling and tracking. Theranostics. 2013;3:544–560. doi: 10.7150/thno.5634. PubMed DOI PMC

Wilhelm C., Gazeau F. Universal cell labelling with anionic magnetic nanoparticles. Biomaterials. 2008;29:3161–3174. doi: 10.1016/j.biomaterials.2008.04.016. PubMed DOI

Malvindi M.A., Greco A., Conversano F., Figuerola A., Corti M., Bonora M., Lascialfari A., Doumari H.A., Moscardini M., Cingolani R., et al. Magnetic/Silica nanocomposites as dual-mode contrast agents for combined magnetic resonance imaging and ultrasonography. Adv. Funct. Mater. 2011;21:2548–2555. doi: 10.1002/adfm.201100031. DOI

Yi P., Chen G., Zhang H., Tian F., Tana B., Dai J., Wang Q., Deng Z. Magnetic resonance imaging of Fe3O4@SiO2-labeled human mesenchymal stem cells in mice at 11.7 T. Biomaterials. 2013;34:3010–3019. doi: 10.1016/j.biomaterials.2013.01.022. PubMed DOI

Talebloo N., Gudi M., Robertson N., Wang P. Magnetic Particle Imaging: Current Applications in Biomedical Research. J. Magn. Reson. Imaging. 2020;51:1659–1668. doi: 10.1002/jmri.26875. PubMed DOI

Klostergaard J., Seeney C.E. Magnetic nanovectors for drug delivery. Nanomedicine. 2012;8:S37–S50. doi: 10.1016/j.nano.2012.05.010. PubMed DOI

Rudzka K., Viota J.L., Muñoz-Gamez J.A., Carazo A., Ruiz-Extremera A., Delgado Á.V. Nanoengineering of doxorubicin delivery systems with functionalized maghemite nanoparticles. Colloids Surf. B Biointerfaces. 2013;111:88–96. doi: 10.1016/j.colsurfb.2013.05.010. PubMed DOI

Olsvik O., Popovic T., Skjerve E., Cudjoe K.S., Hornes E., Ugelstad J., Uhlen M. Magnetic separation techniques in diagnostic microbiology. Clin. Microbiol. Rev. 1994;7:43–54. doi: 10.1128/CMR.7.1.43. PubMed DOI PMC

Haik Y., Pai V., Chen C.-J. Development of magnetic device for cell separation. J. Magn. Magn. Mater. 1999;194:254–261. doi: 10.1016/S0304-8853(98)00559-9. DOI

Brero F., Albino M., Antoccia A., Arosio P., Avolio M., Berardinelli F., Bettega D., Calzolari P., Ciocca M., Corti M., et al. Hadron Therapy, Magnetic Nanoparticles and Hyperthermia: A Promising Combined Tool for Pancreatic Cancer Treatment. Nanomaterials. 2020;10:1919. doi: 10.3390/nano10101919. PubMed DOI PMC

Nemec S., Kralj S., Wilhelm C., Abou-Hassan A., Rols M.-P., Kolosnjaj-Tabi J. Comparison of Iron Oxide Nanoparticles in Photothermia and Magnetic Hyperthermia: Effects of Clustering and Silica Encapsulation on Nanoparticles’ Heating Yield. Appl. Sci. 2020;10:7322. doi: 10.3390/app10207322. DOI

McBain S.C., Yiu H.H., Dobson J. Magnetic nanoparticles for gene and drug delivery. Int. J. Nanomed. 2008;3:169–180. PubMed PMC

Wu W., He Q., Jiang C. Magnetic iron oxide nanoparticles: Synthesis and surface functionalization strategies. Nanoscale Res. Lett. 2008;3:397–415. doi: 10.1007/s11671-008-9174-9. PubMed DOI PMC

Kunzmann A., Andersson B., Vogt C., Feliu N., Ye F., Gabrielsson S., Toprak M.S., Buerki-Thurnherr T., Laurent S., Vahter M., et al. Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol. Appl. Pharmacol. 2011;25:81–93. doi: 10.1016/j.taap.2011.03.011. PubMed DOI

Davila-Ibanez A.B., Salgueirino V., Martinez-Zorzano V., Marino-Fernandez R., Garcia-Lorenzo A., Maceira-Campos M., Muñoz-Ubeda M., Junquera E., Aicart E., Rivas J., et al. Magnetic Silica Nanoparticle Cellular Uptake and Cytotoxicity regulated by Electrostatic Polyelectrolytes-DNA Loading at their Surface. ACS Nano. 2012;6:747–759. doi: 10.1021/nn204231g. PubMed DOI

Biju V. Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy. Chem. Soc. Rev. 2014;43:744–764. doi: 10.1039/C3CS60273G. PubMed DOI

Liberman A., Mendez N., Trogler W.C., Kummel A.C. Synthesis and surface functionalization of silica nanoparticles for nanomedicine. Surf. Sci. Rep. 2014;69:132–158. doi: 10.1016/j.surfrep.2014.07.001. PubMed DOI PMC

Nakamura M., Ishimura K. Synthesis and characterization of organosilica nanoparticles prepared from 3-mercaptopropyltrimethoxysilane as the single silica source. J. Phys. Chem. C. 2007;111:18892–18898. doi: 10.1021/jp075798o. DOI

Mun E.A., Williams A.C., Khutoryanskiy V.V. Adhesion of thiolated silica nanoparticles to urinary bladder mucosa: Effects of PEGylation, thiol content and particle size. Int. J. Pharmaceut. 2016;512:32–38. doi: 10.1016/j.ijpharm.2016.08.026. PubMed DOI

Yan Y., Fu J., Wang T.F., Lu X.Y. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles. Acta Biomater. 2017;51:471–478. doi: 10.1016/j.actbio.2017.01.062. PubMed DOI

Mejias R., Gutierrez L., Salas G., Perez-Yague S., Zotes T.M., Lazaro F.J., Morales M.P., Barber D.F. Long term biotransformation and toxicity of dimercaptosuccinic acid-coated magnetic nanoparticles support their use in biomedical applications. J. Control. Release. 2013;171:225–233. doi: 10.1016/j.jconrel.2013.07.019. PubMed DOI

De Lima R., Oliveira J.L., Murakami P.S.K., Molina M.M., Itri R., Haddad P.S., Seabra A.B. Iron oxide nanoparticles show no toxicity in the comet assay in lymphocytes: A promising vehicle as a nitric oxide releasing nanocarrier in biomedical applications. J. Phys. Conf. Ser. 2013;429:012021. doi: 10.1088/1742-6596/429/1/012021. DOI

Seabra A.B., Pasquôto T., Ferrarini A.C.F., da Cruz Santos M., Haddad P.S., de Lima R. Preparation, Characterization, Cytotoxicity, and Genotoxicity Evaluations of Thiolated-and S-Nitrosated Superparamagnetic Iron Oxide Nanoparticles: Implications for Cancer Treatment. Chem. Res. Toxicol. 2014;27:1207–1218. doi: 10.1021/tx500113u. PubMed DOI

Liu Y., Chen Z., Gu N., Wang J. Effects of DMSA coated Fe3O4 magnetic nanoparticles on global gene expression of mouse macrophage RAW264.7 cells. Toxicol. Lett. 2011;205:130–139. doi: 10.1016/j.toxlet.2011.05.1031. PubMed DOI

Ge G., Wu H., Xiong F., Zhang Y., Guo Z., Bian Z., Xu J., Gu C., Gu N., Chen X., et al. The cytotoxicity evaluation of magnetic iron oxide nanoparticles on human aortic endothelial cells. Nanoscale Res. Lett. 2013;8:215. doi: 10.1186/1556-276X-8-215. PubMed DOI PMC

Oh Y., Je J.Y., Moorthy M.S., Seo H., Cho W.H. pH and NIR-light-responsive magnetic iron oxide nanoparticles for mitochondria-mediated apoptotic cell death induced by chemo-photothermal therapy. Int. J. Pharm. 2017;531:1–3. doi: 10.1016/j.ijpharm.2017.07.014. PubMed DOI

Pisanic T.R., 2nd, Blackwell J.D., Shubayev V.I., Finones R.R., Jin S. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials. 2007;28:2572–2581. doi: 10.1016/j.biomaterials.2007.01.043. PubMed DOI

Zhang J.M., Zhai S.R., Zhai B., An Q.D., Tian G. Crucial Factors Affecting the Physicochemical Properties of Sol–gel Produced Fe3O4@SiO2–NH2 Core–shell Nanomaterials. J. Sol. Gel Sci. Technol. 2012;64:347–357. doi: 10.1007/s10971-012-2864-x. DOI

Stöber W., Fink A., Bohn E. Controlled Growth of Monodisperse Silica Spheres in the Micron Size Range. J. Colloid Interface Sci. 1968;26:62–69. doi: 10.1016/0021-9797(68)90272-5. DOI

Wang Z., Xu J., Hu Y., Zhao H., Zhou J., Liu Y., Lou Z., Xu X. Functional Nanomaterials: Study on Aqueous Hg(II) Adsorption by Magnetic Fe3O4@SiO2-SH Nanoparticles. J. Taiwan Inst. Chem. Eng. 2016;60:394–402. doi: 10.1016/j.jtice.2015.10.041. DOI

Xing Z., Zhu L., Jackson J.A., Gabos S., Sun X.J., Wang X.B., Xu X. Dynamic monitoring of cytotoxicity on microelectronic sensors. Chem. Res. Toxicol. 2005;18:154–161. doi: 10.1021/tx049721s. PubMed DOI

Xing J.Z., Zhu L., Gabos S., Xie L. Microelectronic cell sensor assay for detection of cytotoxicity and prediction of acute toxicity. Toxicol. In Vitro. 2006;20:995–1004. doi: 10.1016/j.tiv.2005.12.008. PubMed DOI

Smith J., Tho L.M., Xu N., Gillespie D.A. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv. Cancer Res. 2010;108:73–112. PubMed

Giacinti C., Giordano A. RB and cell cycle progression. Oncogene. 2006;25:5220–5227. doi: 10.1038/sj.onc.1209615. PubMed DOI

Soenen S.J.H., Nuytten N., De Meyer S.F., De Smedt S.C., De Cuyper M. High intracellular iron oxide nanoparticle concentrations affect cellular cytoskeleton and focal adhesion kinase-mediated signaling. Small. 2010;6:832–842. doi: 10.1002/smll.200902084. PubMed DOI

Choudhury D., Xavier P.L., Chaudhari K., John R., Dasgupta A.K., Pradeep T., Chakrabarti G. Unprecedented inhibition of tubulin polymerization directed by gold nanoparticles inducing cell cycle arrest and apoptosis. Nanoscale. 2013;5:4476–4489. doi: 10.1039/c3nr33891f. PubMed DOI

Schaller M. Paxillin: A focal adhesion-associated adaptor protein. Oncogene. 2001;20:6459–6472. doi: 10.1038/sj.onc.1204786. PubMed DOI

Yue J., Xie M., Gou X., Lee P., Schneider M.D., Wu X. Microtubules regulate focal adhesion dynamics through MAP4K4. Dev. Cell. 2014;31:572–585. doi: 10.1016/j.devcel.2014.10.025. PubMed DOI PMC

Rodriguez O.C., Schaefer A.W., Mandato C.A., Forscher P., Bement W.M., Waterman-Storer C.M. Conserved microtubule-actin interactions in cell movement and morphogenesis. Nat. Cell Biol. 2003;5:599–609. doi: 10.1038/ncb0703-599. PubMed DOI

Ibrahim M., Schoelermann J., Mustafa K., Cimpan M.R. TiO2 nanoparticles disrupt cell adhesion and the architecture of cytoskeletal networks of human osteoblast-like cells in a size dependent manner. J. Biomed. Mater. Res. A. 2018;106:2582–2593. doi: 10.1002/jbm.a.36448. PubMed DOI

Královec K., Havelek R., Koutová D., Veverka P., Kubíčková L., Brázda P., Kohout J., Herynek V., Vosmanská M., Kaman O. Magnetic nanoparticles of Ga-substituted ε-Fe2O3 for biomedical applications: Magnetic properties, transverse relaxivity, and effects of silica-coated particles on cytoskeletal networks. J. Biomed. Mater. Res. A. 2020;108:1563–1578. doi: 10.1002/jbm.a.36926. PubMed DOI

Salasznyk R.M., Klees R.F., Williams W.A., Boskey A., Plopper G.E. Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells. Exp. Cell. Res. 2007;313:22–37. doi: 10.1016/j.yexcr.2006.09.013. PubMed DOI PMC

Mitra S.K., Hanson D.A., Schlaepfer D.D. Focal adhesion kinase: In command and control of cell motility. Nat. Rev. Mol. Cell. Biol. 2005;6:56–68. doi: 10.1038/nrm1549. PubMed DOI

Webb D.J., Donais K., Whitmore L.A., Thomas S.M., Turner C.E., Parsons J.T., Horwitz A.F. FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat. Cell. Biol. 2004;6:54–161. doi: 10.1038/ncb1094. PubMed DOI

Owen J.D., Ruest P.J., Fry D.W., Hanks S.K. Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2. Mol. Cell. Biol. 1999;19:4806–4818. doi: 10.1128/MCB.19.7.4806. PubMed DOI PMC

Seko Y., Takahashi N., Tobe K., Kadowaki T., Yazaki Y. Pulsatile stretch activates mitogen-activated protein kinase (MAPK) family members and focal adhesion kinase [p125(FAK)] in cultured rat cardiac myocytes. Biochem. Biophys. Res. Commun. 1999;259:8–14. doi: 10.1006/bbrc.1999.0720. PubMed DOI

Velarde V., Ullian M.E., Morinelli T.A., Mayfield R.K., Jaffa A.A. Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am. J. Physiol. Cell. Physiol. 1999;277:C253–C261. doi: 10.1152/ajpcell.1999.277.2.C253. PubMed DOI

Sáenz-Morales D., Conde E., Escribese M.M., García-Martos M., Alegre L., Blanco-Sánchez I., García-Bermejo M.L. ERK1/2 mediates cytoskeleton and focal adhesion impairment in proximal epithelial cells after renal ischemia. Cell. Physiol. Biochem. 2009;23:285–294. doi: 10.1159/000218175. PubMed DOI